Investigational Site Number : 8260001

Leicester, Leicestershire LE5 4PW

1 studies enrolling now · 2 studies all time

What they study most

Asthma, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease — Recruiting now
• The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma — Completed